5.03
price down icon1.57%   -0.08
 
loading

Finanzdaten der ProPhase Labs Inc-Aktie (PRPH)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
36.71%
8.365
13.22 19.30 21.85 24.20
Cost Of Revenue
10.80%
6.038
6.769 8.783 10.54 12.23
Gross Profit
63.91%
2.327
6.448 10.52 11.28 11.97
Operating Expenses
20.72%
8.805
11.11 9.645 16.37 10.02
Interest Income/Expense
5.50%
0.275
0.291 0.215 0.129 0.201
Benefits Costs and Expenses
16.44%
15.15
18.13 18.74 27.04 22.42
Costs And Expenses
16.44%
15.15
18.13 18.74 27.04 22.42
Depreciation and Amortization
397.29%
2.571
0.517 1.237 1.15 1.019
Operating Income/Loss
39.07%
-6.478
-4.658 0.875 -5.09 1.953
Income/Loss From Continuing Operations Before Tax
38.07%
-6.785
-4.914 0.564 -5.189 1.777
Income Tax Expense/Benefit
11.53%
-1.644
-1.474 0.014 - -
Income/Loss From Continuing Operations After Tax
49.45%
-5.141
-3.44 0.55 -2.444 0.968
Net Income/Loss
49.45%
-5.141
-3.44 0.55 -2.444 0.968
Preferred Stock Dividends And Other Adjustments
-
- - -0.001 -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
101.86K%
17.18
0.0168 0.0167 15.83 0.0159
Diluted Average Shares
101.86K%
17.18
0.0168 0.0181 18.63 0.0202
Basic Earnings Per Share
50.00%
-0.30
-0.20 0.03 -0.16 0.06
Diluted Earnings Per Share
50.00%
-0.30
-0.20 0.03 -0.08 0.06
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - -0.001 -
$111.07
price down icon 2.96%
diagnostics_research LH
$210.59
price down icon 1.19%
diagnostics_research WAT
$355.95
price down icon 1.26%
$314.72
price down icon 0.35%
diagnostics_research MTD
$1,522.75
price down icon 0.51%
diagnostics_research IQV
$231.18
price down icon 1.63%
Kapitalisierung:     |  Volumen (24h):